title: Are We Getting the Best Return on Investment From Clinical Drug-Drug Interaction Studies?
authors.affiliation: Center for Pharmacometrics and Systems Pharmacology, University of Florida College of Pharmacy, Orlando, Florida, USA.
authors.forename: Lawrence J
authors.initials: LJ
authors.lastname: Lesko
authors.affiliation: Center for Pharmacometrics and Systems Pharmacology, University of Florida College of Pharmacy, Orlando, Florida, USA.
authors.forename: Chakradhar V
authors.initials: CV
authors.lastname: Lagishetty
mesh_terms: D002986:Clinical Trials as Topic / Q000191:economics*; D003362:Cost-Benefit Analysis; D004347:Drug Interactions; D006801:Humans
keywords: drug development; drug interactions; in vitro screening; regulatory guidance